Cargando…

Patients’ Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Patients with Type 1 and Type 2 Diabetes

BACKGROUND: This study quantified how people with diabetes value the unique features of connected insulin pens and related mobile apps, and the underlying reasons for preferring connected versus non-connected insulin pens. METHODS: A discrete choice experiment (DCE) was conducted in the USA and UK t...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Jaein, Heidenreich, Sebastian, Aldalooj, Esraa, Poon, Jiat Ling, Spaepen, Erik, Eby, Elizabeth L., Newson, Rachel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911509/
https://www.ncbi.nlm.nih.gov/pubmed/36437389
http://dx.doi.org/10.1007/s40271-022-00610-x
_version_ 1784885004188254208
author Seo, Jaein
Heidenreich, Sebastian
Aldalooj, Esraa
Poon, Jiat Ling
Spaepen, Erik
Eby, Elizabeth L.
Newson, Rachel S.
author_facet Seo, Jaein
Heidenreich, Sebastian
Aldalooj, Esraa
Poon, Jiat Ling
Spaepen, Erik
Eby, Elizabeth L.
Newson, Rachel S.
author_sort Seo, Jaein
collection PubMed
description BACKGROUND: This study quantified how people with diabetes value the unique features of connected insulin pens and related mobile apps, and the underlying reasons for preferring connected versus non-connected insulin pens. METHODS: A discrete choice experiment (DCE) was conducted in the USA and UK to elicit preferences of adults (≥ 18 years) with type 1 or 2 diabetes for attributes of insulin pens. Attributes included device type, dosing support, glucose monitoring, additional app features, and data sharing. Relative attribute importance (RAI) scores were calculated to capture the relative importance of an attribute. Predicted choice probabilities were obtained to compare different profiles for connected and non-connected insulin pens. RESULTS: The DCE was completed by 540 participants (58.9% male; 90.7% Caucasian; mean age, 58.3 years; 69.4% type 2 diabetes). Participants most valued the possibility of using a connected insulin pen with dosing support and automated dose logging (RAI = 39.9%), followed by automatic transfer of glucose levels (RAI = 29.0%), additional features of tracking diet and physical activity (RAI = 14.6%), data sharing (RAI = 13.6%), and device type (RAI = 2.9%). All profiles of connected insulin pens were preferred over a non-connected pen (p < 0.001), and pen profiles with advanced features were preferred over those without (p < 0.001). Preferences differed by age but not diabetes type, country of residence, or insulin regimen. CONCLUSION: People with diabetes in the USA and UK prefer connected over non-connected insulin pens due largely to the availability of automated logging of dose and glucose levels. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40271-022-00610-x.
format Online
Article
Text
id pubmed-9911509
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-99115092023-02-11 Patients’ Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Patients with Type 1 and Type 2 Diabetes Seo, Jaein Heidenreich, Sebastian Aldalooj, Esraa Poon, Jiat Ling Spaepen, Erik Eby, Elizabeth L. Newson, Rachel S. Patient Original Research Article BACKGROUND: This study quantified how people with diabetes value the unique features of connected insulin pens and related mobile apps, and the underlying reasons for preferring connected versus non-connected insulin pens. METHODS: A discrete choice experiment (DCE) was conducted in the USA and UK to elicit preferences of adults (≥ 18 years) with type 1 or 2 diabetes for attributes of insulin pens. Attributes included device type, dosing support, glucose monitoring, additional app features, and data sharing. Relative attribute importance (RAI) scores were calculated to capture the relative importance of an attribute. Predicted choice probabilities were obtained to compare different profiles for connected and non-connected insulin pens. RESULTS: The DCE was completed by 540 participants (58.9% male; 90.7% Caucasian; mean age, 58.3 years; 69.4% type 2 diabetes). Participants most valued the possibility of using a connected insulin pen with dosing support and automated dose logging (RAI = 39.9%), followed by automatic transfer of glucose levels (RAI = 29.0%), additional features of tracking diet and physical activity (RAI = 14.6%), data sharing (RAI = 13.6%), and device type (RAI = 2.9%). All profiles of connected insulin pens were preferred over a non-connected pen (p < 0.001), and pen profiles with advanced features were preferred over those without (p < 0.001). Preferences differed by age but not diabetes type, country of residence, or insulin regimen. CONCLUSION: People with diabetes in the USA and UK prefer connected over non-connected insulin pens due largely to the availability of automated logging of dose and glucose levels. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40271-022-00610-x. Springer International Publishing 2022-11-28 2023 /pmc/articles/PMC9911509/ /pubmed/36437389 http://dx.doi.org/10.1007/s40271-022-00610-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research Article
Seo, Jaein
Heidenreich, Sebastian
Aldalooj, Esraa
Poon, Jiat Ling
Spaepen, Erik
Eby, Elizabeth L.
Newson, Rachel S.
Patients’ Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Patients with Type 1 and Type 2 Diabetes
title Patients’ Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Patients with Type 1 and Type 2 Diabetes
title_full Patients’ Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Patients with Type 1 and Type 2 Diabetes
title_fullStr Patients’ Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Patients with Type 1 and Type 2 Diabetes
title_full_unstemmed Patients’ Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Patients with Type 1 and Type 2 Diabetes
title_short Patients’ Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Patients with Type 1 and Type 2 Diabetes
title_sort patients’ preferences for connected insulin pens: a discrete choice experiment among patients with type 1 and type 2 diabetes
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911509/
https://www.ncbi.nlm.nih.gov/pubmed/36437389
http://dx.doi.org/10.1007/s40271-022-00610-x
work_keys_str_mv AT seojaein patientspreferencesforconnectedinsulinpensadiscretechoiceexperimentamongpatientswithtype1andtype2diabetes
AT heidenreichsebastian patientspreferencesforconnectedinsulinpensadiscretechoiceexperimentamongpatientswithtype1andtype2diabetes
AT aldaloojesraa patientspreferencesforconnectedinsulinpensadiscretechoiceexperimentamongpatientswithtype1andtype2diabetes
AT poonjiatling patientspreferencesforconnectedinsulinpensadiscretechoiceexperimentamongpatientswithtype1andtype2diabetes
AT spaepenerik patientspreferencesforconnectedinsulinpensadiscretechoiceexperimentamongpatientswithtype1andtype2diabetes
AT ebyelizabethl patientspreferencesforconnectedinsulinpensadiscretechoiceexperimentamongpatientswithtype1andtype2diabetes
AT newsonrachels patientspreferencesforconnectedinsulinpensadiscretechoiceexperimentamongpatientswithtype1andtype2diabetes